{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:55:33Z","timestamp":1792569333655,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4,15]]},"DOI":"10.1093\/infdis\/jis104","type":"journal-article","created":{"date-parts":[[2012,3,22]],"date-time":"2012-03-22T04:59:09Z","timestamp":1332392349000},"page":"1230-1238","source":"Crossref","is-referenced-by-count":111,"title":["Magnitude of Virologic Blips Is Associated With a Higher Risk for Virologic Rebound in HIV-Infected Individuals: A Recurrent Events Analysis"],"prefix":"10.1093","volume":"205","author":[{"given":"J. Troy","family":"Grennan","sequence":"first","affiliation":[{"name":"McMaster University, Hamilton"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona R.","family":"Loutfy","sequence":"additional","affiliation":[{"name":"University of Toronto"},{"name":"Women\u2019s College Hospital, Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DeSheng","family":"Su","sequence":"additional","affiliation":[{"name":"University Health Network, Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Richard","family":"Harrigan","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS, Vancouver"},{"name":"Faculty of Medicine, University of British Columbia, Vancouver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Cooper","sequence":"additional","affiliation":[{"name":"University of Ottawa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Klein","sequence":"additional","affiliation":[{"name":"Montreal Chest Institute"},{"name":"McGill University, Montreal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Machouf","sequence":"additional","affiliation":[{"name":"Clinique Medical L\u2019Actuel, Montreal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio S. G.","family":"Montaner","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS, Vancouver"},{"name":"Faculty of Medicine, University of British Columbia, Vancouver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Rourke","sequence":"additional","affiliation":[{"name":"University of Toronto"},{"name":"St. Michael\u2019s Hospital, Toronto"},{"name":"Ontario HIV Treatment Network, Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Tsoukas","sequence":"additional","affiliation":[{"name":"McGill University, Montreal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Hogg","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Excellence in HIV\/AIDS, Vancouver"},{"name":"Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Raboud","sequence":"additional","affiliation":[{"name":"University of Toronto"},{"name":"University Health Network, Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CANOC Collaboration","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,4,15]]},"reference":[{"key":"key\n\t\t\t\t20180328135149_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"New Engl J Med"},{"key":"key\n\t\t\t\t20180328135149_bib2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.296.7.827","article-title":"Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society\u2014USA Panel","volume":"296","author":"Hammer","year":"2006","journal-title":"J Am Med Assoc"},{"key":"key\n\t\t\t\t20180328135149_bib3","first-page":"1","volume-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2011"},{"key":"key\n\t\t\t\t20180328135149_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2010.1004","article-title":"Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society\u2014USA panel","volume":"304","author":"Thompson","year":"2010","journal-title":"J Am Med Assoc"},{"key":"key\n\t\t\t\t20180328135149_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/135965350200700404","article-title":"Transient rebounds of low-level viraemia among HIV-infected patients under HAART are not associated with virological or immunological failure","volume":"7","author":"Mira","year":"2002","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20180328135149_bib6","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1097\/00002030-200209270-00017","article-title":"Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy","volume":"16","author":"Greub","year":"2002","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328135149_bib7","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/00002030-200210180-00008","article-title":"Prevalence and clinical correlates of HIV viremia (\u201cblips\u201d) in patients with previous suppression below the limits of quantification","volume":"16","author":"Sklar","year":"2002","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328135149_bib8","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1128\/JVI.77.22.12165-12172.2003","article-title":"Viral blip dynamics during highly active antiretroviral therapy","volume":"77","author":"DiMascio","year":"2003","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180328135149_bib9","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.280.5371.1866","article-title":"Toward HIV eradication or remission: the tasks ahead","volume":"280","author":"Ho","year":"1998","journal-title":"Science"},{"key":"key\n\t\t\t\t20180328135149_bib10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jama.293.7.817","article-title":"Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART","volume":"293","author":"Nettles","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328135149_bib11","first-page":"157","article-title":"Update on HIV-1 viral load blips","volume":"1","author":"Nettles","year":"2006","journal-title":"Curr Opin HIV AIDS"},{"key":"key\n\t\t\t\t20180328135149_bib12","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1086\/498025","article-title":"Transient viremia in HIV-infected patients and use of plasma preparation tubes","volume":"41","author":"Stosor","year":"2005","journal-title":"Clin Infec Dis"},{"key":"key\n\t\t\t\t20180328135149_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/QAI.0b013e3181aa13b3","article-title":"Increased frequency of HIV-1 viral load blip rate observed after switching from Roche Amplicor to Cobas Taqman Assay","volume":"51","author":"Smit","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328135149_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/QAI.0b013e31819e721b","article-title":"Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay","volume":"51","author":"Lima","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328135149_bib15","article-title":"Variations in HIV RNA assays at low RNA concentration [abstract 774]","volume-title":"Program and abstracts of the 7th Conference on Retroviruses and Opportunistic Infections","author":"Brambilla","year":"2000"},{"key":"key\n\t\t\t\t20180328135149_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.286.2.171","article-title":"Prevalence and predictive value of intermittent viremia with combination HIV therapy","volume":"286","author":"Havlir","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328135149_bib17","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/00002030-200208160-00008","article-title":"Consecutive rebounds in plasma viral load are associated with virological failure at 52 weeks among HIV-infected patients","volume":"16","author":"Raboud","year":"2002","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328135149_bib18","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/01.aids.0000174453.55627.de","article-title":"HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen","volume":"19","author":"Martinez","year":"2005","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328135149_bib19","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1086\/496985","article-title":"Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis","volume":"41","author":"Sungkanuparph","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328135149_bib20","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1086\/523704","article-title":"Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia","volume":"196","author":"Podsadecki","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328135149_bib21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jac\/dkm516","article-title":"Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome","volume":"61","author":"Garcia-Gasco","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328135149_bib22","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/00002030-200207260-00009","article-title":"The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to <400 copies\/mL","volume":"16","author":"Easterbrook","year":"2002","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328135149_bib23","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00002030-200203080-00013","article-title":"Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?","volume":"16","author":"Moore","year":"2002","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328135149_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jcv.2004.11.012","article-title":"Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance","volume":"33","author":"Masquelier","year":"2005","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20180328135149_bib25","article-title":"What should be the primary virological endpoint in clinical trials of ARV efficacy? [Paper 661]","volume-title":"Program and abstracts of the 18th Conference on Retroviruses and Opportunistic Infections","author":"Harrigan","year":"2011"},{"key":"key\n\t\t\t\t20180328135149_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00126334-200110010-00001","article-title":"Transient relapses (\u201cblips\u201d) of plasma HIV RNA levels during HAART are associated with drug resistance","volume":"28","author":"Cohen Stuart","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328135149_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jinf.2004.11.010","article-title":"Transient rebounds of HIV plasma viremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy","volume":"51","author":"Macias","year":"2005","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180328135149_bib28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/infdis\/jir353","article-title":"Antiretroviral drug resistance in HIV-1\u2013infected patients experiencing persistent low-level viremia during first line therapy","volume":"204","author":"Taiwo","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328135149_bib29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1310\/FFTX-WQ4H-PFJM-GA8M","article-title":"Analyzing plasma HIV-1 RNA measurements as multiple recurrent events in clinical trials","volume":"7","author":"Flandre","year":"2006","journal-title":"HIV Clin Trials"},{"key":"key\n\t\t\t\t20180328135149_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1468-1293.2007.00427.x","article-title":"Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment","volume":"8","author":"Srasuebkul","year":"2007","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20180328135149_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ije\/dyp393","article-title":"Cohort profile: the Canadian Observational Cohort collaboration","volume":"40","author":"Palmer","year":"2011","journal-title":"Int J Epidemiol"},{"key":"key\n\t\t\t\t20180328135149_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8240(02)00095-2","article-title":"The distribution of viral blips observed in HIV-1\u2013infected patients treated with combination antiretroviral therapy","volume":"65","author":"Percus","year":"2003","journal-title":"Bull Math Biol"},{"key":"key\n\t\t\t\t20180328135149_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mbs.2003.08.003","article-title":"Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy","volume":"188","author":"DiMascio","year":"2004","journal-title":"Math Biosci"},{"key":"key\n\t\t\t\t20180328135149_bib34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/biomet\/68.2.373","article-title":"On the regression analysis of multivariate failure time data","volume":"68","author":"Prentice","year":"1981","journal-title":"Biometrika"},{"key":"key\n\t\t\t\t20180328135149_bib35","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/382895","article-title":"No evidence of an association between transient HIV viremia (\u201cblips\u201d) and lower adherence to the antiretroviral medication regimen","volume":"189","author":"Miller","year":"2004","journal-title":"J Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/205\/8\/1230\/11651394\/jis104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T09:34:45Z","timestamp":1687340085000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/205\/8\/1230\/877021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,15]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2012,4,15]]},"published-print":{"date-parts":[[2012,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jis104","relation":{},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,4,15]]},"published":{"date-parts":[[2012,4,15]]}}}